Ukraine in January-July 2019 exported 243,710 tonnes of poultry, which is 32% more than in the same period in 2018, the State Fiscal Service has reported. According to its data, in monetary terms exports of these products increased by 23%, to $356.57 million.
Poultry and offal imports for the seven months fell by 2.9%, to 71,240 tonnes, in monetary terms by 2.3%, to $28.62 million.
According to the State Fiscal Service, exports of pork in January-July 2019 rose by 2.7% compared to the corresponding period of 2018, to 1,200 tonnes. In monetary terms exports of this product amounted to $2.65 million (1.3%).
Pork imports to Ukraine during this period grew by 11.7%, to 13,580 tonnes. The country received this meat for a total of $25.71 million that is 14% more compared to the previous seven months.
The State Service of Ukraine for Food Safety and Consumers’ Rights Protection and the competent authority of the Sultanate of Oman have agreed on the requirements for exports of Ukrainian dairy products to Oman, the press service of the Ukrainian agency has said.
According to information on the website of the service, Ukrainian manufacturers must provide a veterinary certificate, a certificate of origin of products and a certificate of tests for radiation.
According to the agency, the work on the promotion of Ukrainian dairy products to the markets of other countries of the Persian Gulf continues.
As reported, Ukraine in 2018 opened 85 export markets for various types of products and increased the number of enterprises that received the right to export food of animal origin. Some 126 national producers are allowed to export food to EU countries.
India could expand a portfolio of generics exported to Ukraine thanks to medications that lost patent protection of innovative drugs, which will become available before 2020, President of the Indian Pharmaceutical Manufacturers’ Association (IPMA) Dr. Ramanan Unni Parambath Menon has told Interfax-Ukraine. “Exports of Indian pharmaceutical products will grow, and the portfolio of generic products that can be supplied to Ukraine will expand, since by 2020 branded drugs worth about $55 billion will lose patent protection,” he said on the sidelines of the annual business seminar “India – Global force in pharmaceutics – Reliable partner for Ukraine” held late November in Kyiv.
He said that at present, retail and hospital sales of Indian medicines account for more than UAH 2.633 billion per year, including UAH 334.3 million in the hospital segment. The share of branded generic production of Indian pharmaceutical companies is 59.4% of this segment. According to Dr. Menon, “generic products are market drivers.” “The share of generic drugs is growing in monetary terms and in kind. Products of Indian companies are more branded generics,” he said.
Currently, the top 10 Indian pharmaceutical companies on the Ukrainian market include five IPMA member companies – Dr. Reddys, Abryl Formulations, Organosyn Life Sciences, SUN Pharma, Macleods Pharmaceuticals; and two IPMA member companies are in the top 20 – Aurobindo Pharma and Hetero Labs.
In total, 365 Indian brands are currently represented in the Ukrainian pharmaceutical market.
The IPMA predicts that by the end of 2018, sales of Indian medicines in Ukraine will grow by 22.7% in hryvnias or 19.9% in U.S. dollars compared with 2017. At the same time, sales of Indian drugs in kind will increase by 2.5%.
The growth in sales of Indian pharmaceutical products in 2019 in monetary terms could be 18.1% in hryvnias or 9.5% in U.S. dollars, while maintaining the total supply volumes.